BLOG
Filter by Healthtech, Securetech, Urbantech, Portfolio Company News, Dreamit Dose
Featured
In our latest Securetech newsletter, we gave you a list of the top 5 doses of 2021, specifically for security startups. In case you missed it, here’s the list.
Ever wonder why so many of your cold emails to investors and potential customers go unanswered? It’s no surprise, everyone’s inbox is overflowing and most people who get a cold email just ignore it. In this Dose, Steve Barsh, Managing Partner at Dreamit Ventures, shares his pro tips on how to perfectly craft a cold email to investors and prospects.
Ready to answer VC questions like a pro? In this Dose, Mike Ravenscroft, Startup Success Manager at Dreamit Ventures, gives you 5 common mistakes to avoid in order to tighten up your answers to VC and customer questions. Get the art of answering investor and customer questions in a short 6-minute Dreamit Dose!
A channel sales strategy is crucial to scaling a startup. However, most startups fail to launch and execute a successful channel sales program. Securetech Managing Director, Mel Shakir, brought Evan Blair to the Dreamit Dose to share his experience leading global channel sales and partner programs at ZeroFox, Accuvant, and Ciphent over the past decade.
Raising early-stage funding? You’ll need to know the ins and outs of convertible notes and SAFEs. In this Dreamit Dose, Steve Barsh, Managing Partner at Dreamit, gives you his breakdown and tells you what issues to avoid on these early-stage financing instruments. You’ll learn 6 key points to be prepared and ready the next time you’re structuring a convertible note or SAFE financing.
We see so many startups struggle to raise a round. They think they’re doing everything correctly when they pitch, but there’s a subtle yet critical flaw -- they’re pitching, but not telling a compelling and believable “story.”
The ‘How much are you raising?’ question is a common and important component of investor Q&A. Seasoned founders have a particular way of answering this question. In this Dreamit Dose, Managing Director Adam Dakin presents his view on the right way to answer it after hearing hundreds, if not thousands, of founder pitches.
Board meetings can be very powerful events where founders get valuable feedback, ideas, and strategic direction. Read for Dreamit Managing Partner, Steve Barsh’s 5 tips founders can use to get a lot more out of their board meetings and make them a product and positive experience for everyone involved.
The "What’s your valuation?" question is a common component of investor Q/A. You need to be aware of and ready for this tough question from investors. In this Dreamit Dose, Managing Director Adam Dakin reveals the right approach on how to answer the valuation question when pitching VCs.
We teamed up with Annie Duke, world champion poker player and author of “Thinking in Bets” and her newest book “How to Decide”, for this guest Dreamit Dose to help founders make better decisions.
We did a previous dose on 5 things investors wish startups knew. Well, that didn’t cover everything. Managing Partner, Steve Barsh, sat down to give us 5 MORE things investors wish startups knew. Keep reading for some more of the most common mistakes startups make when pitching and for Steve’s tips on how to fix them.
2020 was a mixed bag for healthcare ventures. It rapidly accelerated the adoption of some healthtech subsets, while stymied clinical progress and enterprise traction for others. So here we'll summarize healthtech investing trends from this last year and highlight lessons learned from enterprise healthcare leaders.
The venture capital screening call is an important step to get right in due diligence. To get to partners, often you’ll have to go through the associate first. In this Dreamit Dose, associates Alana Hill and Elliot Levy offer five things they wish founders knew after screening over 1,000 startups in the last year.
Mel Shakir, Securetech Managing Director with over 15 years of experience in bringing innovative cybersecurity solutions to market, is back to give his tips on product management.
When looking at angel investors vs. venture capitalists, there are a few differences regarding when to reach out to them and what motivates them to do deals. Jason, an experienced angel, gives his insight on what motivates angel investors, and how you can most effectively get an angel to be part of your team.
Most VC investors see hundreds, if not thousands, of startup decks and pitches each year. In this article, we’ll outline Managing Partner Steve Barsh’s top 5 things investors wish startup founders knew when reaching out, sending a deck, or pitching a VC.
Dreamit Ventures and MedCityNews teamed up to get a pulse on the current appetite for innovation at large health systems across the United States. The survey data tapped senior innovation leaders, 85% of whom came from health systems with over 1,000 beds.
Mel Shakir, Securetech Managing Director, talks to CISOs every day in his role at Dreamit. He coaches companies to get them ready to sell to a CISO. However, he also coaches them on what to avoid. In this Dreamit Dose, Mel gives you 5 reasons a CISO may NOT buy your product.
Are you pitching over Zoom? Avoid these common virtual pitch mistakes founders often make. In this Dreamit Dose, Adam Dakin (MD of Dreamit Healthtech) offers a couple of simple rules that have come to light watching founders pitch virtually during the pandemic. These are easy to fix if you follow this guide.
Most founders consider two possibilities when thinking about their exit strategy: IPO or acquisition. The process of startup M&A likely remains shrouded in mystery for founders who have never seen it first-hand. We invited Amit Yoran, CEO of Tenable, and Mike Viscuso, Co-Founder of Carbon Black, on #DreamitLive to answer these questions and more. We pulled out 5 key lessons from the discussion to shed some light on M&A and help you navigate what can either be an extremely rewarding or painful process.
Traction is one of the most important elements to nail when pitching investors. The problem is, most startups do a poor job talking about it. In this Dreamit Dose, Managing Partner Steve Barsh highlights pro tips and traction insights across all early stages of the startup lifecycle. From pre-revenue early traction to post-revenue momentum, this Dose will teach you the ins and outs of presenting traction to investors.
Uncertainty and startups go hand in hand. Whether you’re planning micro-pivots to product development or macro-pivots in light of recent market change, you’ll need a well-tuned internal schema to assess uncertainty. In the wake of the pandemic, startups across all stages have been pressed to make swift decisions and adjust plans. Today, more than ever, the relevant question founders should be asking themselves is: what’s my bet?
Speaking to investors can require a language of its own. Word choice is important and even the smallest detail can make or break your startup pitch. Adam Dakin, Managing Director of Dreamit Healthtech, sees founders make the same common pitch mistakes over and over. Luckily, he’s a pro when it comes to pitching investors and distills the advice so it’s easy to avoid. In this Dreamit Dose, Adam dives into the language of the pitch and flags three common mistakes you’ll want to avoid.
Today, Infermedica (HT ‘18) announced a $10M Series A financing round for their AI-driven platform that helps insurance, telemedicine companies, and health systems increase efficiency through fast, digital symptom-checks. The platform has nearly 60 B2B partners across 30 countries, including Microsoft, Allianz, Global Excel, Sana Kliniken, and Médis, and has performed more than 6 million health checks globally. Read here.
TrekIT Health (HT- ‘18) announced closing $1M in additional seed financing. TrekIt’s technology is a HIPAA compliant and secure, real-time workspace for synthesizing information across EHRs and care teams. Clinicians love TrekIT because of its intuitive and predictive interface which serves as a cure for disjointed information systems and a replacement for paper task lists. Read more.
To keep an organization safe, a CISO depends on as many as 50 to 100 different products. This presents a huge opportunity for startups. However, this means that a CISO sees a LOT of pitches in their role. In this Dreamit Dose, Mel tells you the five ways to get a CISO to buy your product.
When you’re raising a bridge round and pitching investors, their first reaction may be that you’re in trouble. To overcome this, you’ll need to understand how to frame your bridge round ask, overcome assumptions investors often make, and how to structure startup bridge round pitches.
Ruvna, a safety and communication platform for school systems, is releasing a new product this fall providing COVID-19 screening, tracking, and compliance for schools and districts called Ruvna Health. Learn more about the solution here.